🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

42 results for “The University of Hong Kong” Clear

  1. Dexmedetomidine

    The University of Hong Kong

    Anxiety, Separation

    approved small molecule active

    1 trial

  2. Ivabradine + Usual Care

    The University of Hong Kong

    Atrial Fibrillation (Permanent)

    approved small molecule active

    1 trial

  3. Oral hygiene intervention

    The University of Hong Kong

    Acute Stroke

    approved other completed

    1 trial

  4. Paracetamol

    The University of Hong Kong

    Influenza

    approved small molecule completed

    1 trial

  5. Rivaroxaban 2.5 MG Oral Tablet [Xarelto]

    The University of Hong Kong

    Atherosclerosis, Coronary

    approved small molecule completed

    1 trial

  6. Trivalent live attenuated seasonal influenza vaccine

    The University of Hong Kong

    Influenza Virus Infection

    approved mab completed

    1 trial

  7. Exforge HCT® or Three Individual drug amlodipine + valsartan + hydrochlorothiazide

    The University of Hong Kong

    Intracerebral Hemorrhage

    small molecule active

    1 trial

  8. Fluoxetine

    The University of Hong Kong

    Depression

    small molecule completed

    1 trial

  9. Inactivated influenza vaccine

    The University of Hong Kong

    Influenza Virus Infection

    mab completed

    1 trial

  10. Mailed nicotine replacement therapy (NRT)

    The University of Hong Kong

    Smoking Cessation

    small molecule active

    1 trial

  11. NRT-S

    The University of Hong Kong

    Smoking Cessation

    small molecule completed

    1 trial

  12. Nicotine Replacement therapy

    The University of Hong Kong

    Smoking

    small molecule active

    1 trial

  13. Paclitaxel, gemcitabine or liposomal doxorubicin with or without bevacizumab or biosimilar

    The University of Hong Kong

    Recurrent Ovarian Carcinoma

    small molecule active

    1 trial

  14. Ping On Ointment

    The University of Hong Kong

    Temporomandibular Disorders

    small molecule completed

    1 trial

  15. Propofol

    The University of Hong Kong

    Anesthesia

    small molecule active

    1 trial

  16. TIV 2010/2011 influenza vaccine

    The University of Hong Kong

    Influenza

    mab completed

    1 trial

  17. indocyanine green

    The University of Hong Kong

    Anastomotic Leak

    small molecule active

    1 trial

  18. sevelamer hydrochloride

    The University of Hong Kong

    Endstage Renal Disease

    small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources